Moderna Inc (MRNA) support and resistance · rev $145.0M
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
This page maps Moderna Inc (MRNA) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
MRNA currently screens at market cap $24.52B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new MRNA 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the MRNA quote page for the session range and the stock page for the full model.
Not investment advice.